{
    "nct_id": "NCT03129061",
    "official_title": "A Pilot Study to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)",
    "inclusion_criteria": "* Unresectable or metastatic SCCHN.\n* Localized SCCHN.\n* >18 years old.\n* Willing and able to sign consent form.\n* Have standard of care biopsy or resection planned or tumors amenable to serial biopsies.\n* For patients with reproductive potential must undergo counseling to understand unknown risks to resultant progeny.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Diagnosis of immunodeficiency or active autoimmune condition.\n* Active tuberculosis\n* Prior exposure to PD-1 or PD-LI treatment\n* Prior systemic chemotherapy within 2 weeks of planed anti-PD1 treatment.\n* Received a live vaccine within 30 days of planned PD-1 start date.\n* Pregnant or breastfeeding.",
    "miscellaneous_criteria": ""
}